Huimahn Choi, MD
Neurocritical Care · Houston, TXNPI 1841443108
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,950 of the $2,254 with a category attached, or 86.5%. Medtronic accounts for 86.5% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $1,950 and has fallen 98.3% since, to $33 in 2025. Among neurocritical care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 6 payments — averaging $375.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- UCB, Inc.$159
- Integra Lifesciences Corporation$71
- Potrero Medical, Inc.$40
- BD$33
Across 17 payments — averaging $30,761 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$318K
- C. R. Bard, Inc. & Subsidiaries$198K
- Davol Inc.$8K
What the payments were for
- Speaking & faculty fees$1,95087%
- Food & beverage$30413%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $1,950 |
| UCB, Inc. | 1 | $159 |
| Integra Lifesciences Corporation | 1 | $71 |
| Potrero Medical, Inc. | 2 | $40 |
| BD | 1 | $33 |
How this compares
$2,254 in reported general payments places this provider in the 90th percentile of 46 neurocritical care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Houston
- Ashutosh MahapatraHouston$27K
- Ritvij BowryHouston$11K
- Muhammad Ubaid HafeezHouston$2K
- Tiffany ChangHouston$816
- Abhay KumarHouston$723
- Aaron GusdonHouston$661
- Luis TorresHouston$449
- Swathi KondapalliHouston$389
- Robert BrownHouston$222
- Eman AlnosairHouston$207
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.